Baby pain study halted: did standard care pass the test?
NCT ID NCT02860091
First seen May 22, 2026 · Last updated May 22, 2026
Summary
This study looked at how much of the pain medicine ropivacaine gets into the blood of infants and toddlers after chest surgery. The goal was to make sure the standard nerve block treatment is safe. The study was stopped early, but the information gathered helps doctors understand how this medicine works in young children.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN, POSTOPERATIVE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Boston Children"S Hospital
Boston, Massachusetts, 02118, United States
Conditions
Explore the condition pages connected to this study.